Inactivation of Lysozyme in a Solution Containing Sodium Bisulfite under Scattered Light(Pharmaceutical)
スポンサーリンク
概要
- 論文の詳細を見る
When a solution(pH 4.0) containing 1 mg/ml hen egg-white lysozyme(EC 3.2.1.17) and 1 mM sodium bisulfite (SBS) was stored at 3℃ under scattered light, the residual activity of lysozyme was reduced to about 10% within 3d. The inactivation was dependent on the pH of the medium, and was especially marked at pH below 5. It was largely prevented by shielding the solution from light, by replacement of the dissolved oxygen in the medium by nitrogen gas and by the addition of several radical scavengers to the medium prior to storage. The absorbance of lysozyme treated with SBS for 3d under scattered light was decreased by about 10% at 280nm, and the content of tryptophan residues of lysozyme was decreased by about 1.0 mol of Trp/moi of enzyme. The change in the state of aromatic amino acid residues of lysozyme treated with SBS under scattered light was observed by circular dichroism spectral analysis in the wavelength range of 250-340 nm, and this change was prevented by shielding from light and by addition of radical scavengers. These results suggest that the inactivation of lysozyme during storage in a solution containing SBS was due to modification or destruction of amino acid residues in lysozyme by free radicals formed during the autooxidation of bisulfite under scattered light.
- 公益社団法人日本薬学会の論文
- 1987-06-25
著者
-
森田 邦彦
滋賀医科大学医学部附属病院薬剤部:(現)慶應義塾大学病院薬剤部
-
小野 彪
滋賀医科大学医学部附属病院薬剤部
-
島川 治巳
滋賀医科大学医学部附属病院薬剤部
-
小野 彪
Hospital Pharmacy, Shiga University of Medical Science
-
島川 治巳
Hospital Pharmacy, Shiga University of Medical Science
-
森田 邦彦
Hospital Pharmacy, Shiga University of Medical Science
-
西田 由美子
Hospital Pharmacy, Shiga University of Medical Science
-
西田 由美子
Hospital Pharmacy Shiga University Of Medical Science
関連論文
- O-91 MRSA 感染症患者に対するバンコマイシン持続投与の有効性評価と腎機能に対応した投与量設定法の構築
- 25-04-02 MRSA 感染症患者におけるテイコプラニン血中濃度と治療効果の関係解析
- シメチジンの用量と薬物相互作用発現の関係 : 文献調査ならびにテオフィリン体内動態の変動
- 13-7-3 TDM をとおしての医師へのアドバイスの重要性 : ジゴキシンおよびフェニトインに関する retrospective study
- 14-6-22 シメチジンの用量を考慮した相互作用チェックの必要性
- 投与間隔設定用ノモグラムを利用したバンコマイシンの処方適正化と添付文書記載内容の検討
- P-B-2-4 バンコマイシンの処方適正化に向けての取り組み : 投与間隔設定用ノモグラムの有用性と添付文書記載内容の検討
- 光過敏性てんかん患者における異常脳波誘発時の血清α_1酸性糖タンパク質濃度の変動
- Multiplicity of Cytochrome P-450 Species Involved in Theophylline Metabolism in Mouse Hepatic Microsomes
- 自動分割分包機による散・顆粒配合剤の一段分割法と二段分割法の検討
- 腎移植患者の精液中のCiclosporin濃度の検討
- Effects of Temperature and Endogenous Factors in Blood on Concentrations of Cyclosporin in Plasma Measured by High-Performance Liquid Chromatography
- 自動分割分包機による散剤・顆粒剤混合物の分割後の均一性の検討
- 自動分割分包機による分割後の重量変動の検討
- A-30 スピロノラクトン/アプリンジン相互作用
- 薬局窓口における外来患者からの質問の動機と背景の分析
- 粉末薬剤の安定性と保存湿度の関係
- 13-4-B2 抗不整脈薬・シベンゾリンの副作用発現と投与量の関係
- Ozagrel Hydrochloride Monohydrate, a Thromboxane Synthase Inhibitor, and Its Metabolites as Inhibitors of Hepatic Microsomal Drug Metabolism
- The Effects of H_2-Receptor Antagonists and Imidazole on Testosterone Hydroxylations in Mouse Liver Microsomes
- 血中濃度からみたジゴキシンの用量設定に関する現状分析と, 患者腎機能に対応した用量設定に向けての簡便な指標の構築
- 添付文書に不足しているTDM情報 (特集 これからの医療とTDM)
- Stereoselectivity in the Hydroxylation of Propafenone Enantiomers in Mouse Hepatic Microsomes
- Fluconazole : A Potent Inhibitor of Cytochrome P-450-Dependent Drug-Metabolism in Mice and Humans in Vivo. Comparative Study with Ketoconazole
- マウス肝ミクロソームにおけるDisopyramide光学異性体のN-脱アルキル化代謝の立体選択性
- 肝ミクロソームの酸化的薬物代謝酵素(チトクロムP-450)系に対する合成ステロイド剤・Danazolの阻害作用
- Inactivation of Lysozyme in a Solution Containing Sodium Bisulfite under Scattered Light(Pharmaceutical)
- Comparison of the Effects of Feprazone and Phenylbutazone on Testosterone Hydroxylations in Mouse Hepatic Microsomes
- B-18 各種病態モデル・ラットにおける Cyclosporin A 静脈内投与後の体内動態
- 活性炭を用いた制御徐放性注腸液の調製
- Pharmacokinetics of Cyclosporin A after Intravenous Administration to Rats in Various Disease States
- 粉米薬剤の吸湿性の検討
- High-Performance Liquid Chromatographic Determination of 6β-Hydroxycortisol in Urine
- Erythrocyte Uptake and Protein Binding of Cyclosporin A (CyA) in Human Blood : Factors Affecting CyA Concentration in Erythrocytes
- Inducing effect of carbamazepine on oxidative drug-metabolizing enzymes in children.
- An Improved High-Performance Liquid Chromatographic Method for Determination of Urinary 17-Hydroxycorticosteroids
- Pharmacokinetic and Pharmacodynamic Data Analysis of Diltiazem on Treadmill Exercise Testing.
- Inhibitory action of ozagrel (OK-046), an inhibitor of thromboxane A2 synthetic enzyme and its metabolites on liver microsome oxydative drug metabolizing enzyme.
- Inhibitory effect of drug metabolizing enzyme system by antifungal agent, fluconazole.
- Changes in blood .ALPHA.1-acid glycoprotein level in epileptic patient.
- Pharmacokinetics of cyclosporin A in kidney transplantation patient.The relevance to pharmacokinetics parameter and renal function.
- Effect of various imidazole drugs on testosterone biosynthesis enzyme system of the testis.